These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9544235)
1. HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Yu M; Kinkel RP; Weinstock-Guttman B; Cook DJ; Tuohy VK Hum Immunol; 1998 Jan; 59(1):15-24. PubMed ID: 9544235 [TBL] [Abstract][Full Text] [Related]
2. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls. Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969 [TBL] [Abstract][Full Text] [Related]
3. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK; Yu M; Yin L; Kawczak JA; Johnson JM; Mathisen PM; Weinstock-Guttman B; Kinkel RP Immunol Rev; 1998 Aug; 164():93-100. PubMed ID: 9795767 [TBL] [Abstract][Full Text] [Related]
4. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease. Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163 [TBL] [Abstract][Full Text] [Related]
5. Diversity and plasticity of self recognition during the development of multiple sclerosis. Tuohy VK; Yu M; Weinstock-Guttman B; Kinkel RP J Clin Invest; 1997 Apr; 99(7):1682-90. PubMed ID: 9120012 [TBL] [Abstract][Full Text] [Related]
6. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
7. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype. Kagnoff MF; Harwood JI; Bugawan TL; Erlich HA Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6274-8. PubMed ID: 2788285 [TBL] [Abstract][Full Text] [Related]
8. Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF J Neuroimmunol; 1993 Jul; 46(1-2):33-42. PubMed ID: 7689593 [TBL] [Abstract][Full Text] [Related]
9. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. Yu M; Johnson JM; Tuohy VK J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934 [TBL] [Abstract][Full Text] [Related]
10. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation. Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326 [TBL] [Abstract][Full Text] [Related]
11. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. Khare M; Rodriguez M; David CS Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683 [TBL] [Abstract][Full Text] [Related]
12. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice. Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661 [TBL] [Abstract][Full Text] [Related]
13. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls. Pelfrey CM; Tranquill LR; Vogt AB; McFarland HF Mult Scler; 1996 Apr; 1(5):270-8. PubMed ID: 9345429 [TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Fogdell-Hahn A; Ligers A; Grønning M; Hillert J; Olerup O Tissue Antigens; 2000 Feb; 55(2):140-8. PubMed ID: 10746785 [TBL] [Abstract][Full Text] [Related]
15. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413 [TBL] [Abstract][Full Text] [Related]
16. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in Japanese. Yamagata K; Hanafusa T; Nakajima H; Sada M; Amemiya H; Tomita K; Miyagawa J; Noguchi T; Tanaka T; Kono N Tissue Antigens; 1991 Sep; 38(3):107-10. PubMed ID: 1686679 [TBL] [Abstract][Full Text] [Related]
17. Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein. Ruiter B; Rozemuller EH; van Dijk AJ; Garssen J; Bruijnzeel-Koomen CA; Tilanus MG; Knol EF; van Hoffen E Int Arch Allergy Immunol; 2007; 143(2):119-26. PubMed ID: 17228168 [TBL] [Abstract][Full Text] [Related]
18. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667 [TBL] [Abstract][Full Text] [Related]
19. DNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi's disease). Tanaka T; Ohmori M; Yasunaga S; Ohshima K; Kikuchi M; Sasazuki T Tissue Antigens; 1999 Sep; 54(3):246-53. PubMed ID: 10519361 [TBL] [Abstract][Full Text] [Related]